Is angiopoietin-2 the key piece in the sepsis puzzle?

Critical Care Medicine

Volumn 40, Issue 11, 2012, Pages 3100-3101

  Liles, W Conrad ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

angiopoietin 2; endothelium; multiorgan dysfunction syndrome; sepsis; vascular leak

Indexed keywords

ANGIOPOIETIN 2; DROTRECOGIN;

CRITICALLY ILL PATIENT; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; INTENSIVE CARE; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS;

ANGIOPOIETIN-2; ANIMALS; FEMALE; HUMANS; MALE; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 84868253315     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182653413     Document Type: Editorial

References (20)

1. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
2. Lever A, Mackenzie I: Sepsis: Definition, epidemiology, and diagnosis. BMJ 2007; 335: 879-883
3. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777
4. Goldenberg NM, Steinberg BE, Slutsky AS, et al: Broken barriers: A new take on sepsis pathogenesis. Sci Transl Med 2011; 3:88ps25
5. Lee WL, Liles WC: Endothelial activation, dysfunction and permeability during severe infections. Curr Opin Hematol 2011; 18:191-196
6. Hawiger J, Musser JM: How to approach genome wars in sepsis? Crit Care 2011; 15:1007
7. Xing K, Murthy S, Liles WC, et al: Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review. Crit Care 2012; 16:R7
8. David S, Mukherjee A, Ghosh CC, et al: Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis. Crit Care Med 2012; 40:3034-3041
9. Parikh SM, Mammoto T, Schultz A, et al: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46
10. Giuliano JS Jr, Lahni PM, Harmon K, et al: Admission angiopoietin levels in children with septic shock. Shock 2007; 28:650-654
11. Kümpers P, Lukasz A, David S, et al: Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008; 12:R147
12. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, et al: Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008; 63:903-909
13. Siner JM, Bhandari V, Engle KM, et al: Elevated serum angiopoietin 2 levels are associated with increased mortality in sepsis. Shock 2009; 31:348-353
14. Ricciuto DR, dos Santos CC, Hawkes M, et al: Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011; 39:702-710
15. Calfee CS, Gallagher D, Abbott J, et al; NHLBI ARDS Network: Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance. Crit Care Med 2012; 40: 1731-1737
16. Witzenbichler B, Westermann D, Knueppel S, et al: Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111:97-105
17. Mei SH, McCarter SD, Deng Y, et al: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007; 4:e269
18. Novotny NM, Lahm T, Markel TA, et al: Angiopoietin-1 in the treatment of ischemia and sepsis. Shock 2009; 31:335-341
19. David S, Park JK, Meurs M, et al: Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine 2011; 55:251-259
20. Kümpers P, Gueler F, David S, et al: The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011; 15:R261